| BMYBRISTOL MYERS SQUIBB CO | 827,901 | $50.2M |
| MRKMerck & Co., Inc. | 260,340 | $31.3M |
| PFEPFIZER INC | 1,091,385 | $30.6M |
| INCYIncyte Corp. | 200,510 | $18.9M |
| AMGNAMGEN INC | 47,155 | $16.6M |
| BIIBBIOGEN INC. | 90,096 | $16.5M |
| ZBHZimmer Biomet Holdings Inc. | 155,835 | $14.1M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 239,918 | $13.6M |
| ELVElevance Health Inc. | 43,962 | $12.9M |
| IONSIONIS PHARMACEUTICALS INC | 169,468 | $12.7M |
| CAHCardinal Health Inc. | 54,897 | $11.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 36,435 | $9.9M |
| GEHCGE HealthCare Technologies Inc. | 126,418 | $9.0M |
| ABTABBOTT LABORATORIES | 87,532 | $9.0M |
| GILDGILEAD SCIENCES, INC. | 53,247 | $7.4M |
| LNTHLantheus Holdings, Inc. | 93,344 | $7.1M |
| IQVIQVIA Holdings Inc. | 40,230 | $6.9M |
| SNDXSyndax Pharmaceuticals Inc | 286,007 | $6.7M |
| QGENQIAGEN N.V. | 162,371 | $6.5M |
| PTCTPTC THERAPEUTICS, INC. | 75,000 | $5.1M |
| CRNXCrinetics Pharmaceuticals, Inc. | 94,195 | $3.4M |
| KURAKura Oncology, Inc. | 411,810 | $3.3M |
| BBIOBridgeBio Pharma, Inc. | 44,263 | $3.3M |
| IOVAIOVANCE BIOTHERAPEUTICS, INC. | 900,000 | $3.2M |
| DNLIDenali Therapeutics Inc. | 162,710 | $3.1M |
| ARDXARDELYX, INC. | 516,131 | $3.1M |
| COGTCogent Biosciences, Inc. | 80,000 | $3.1M |
| OGNOrganon & Co. | 375,974 | $2.3M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 30,000 | $1.9M |